即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1370261-97-4 | 货号 | BCP09980 |
中文名 | PRT062607 HCl | ||
英文名 | PRT062607 HCl | ||
中文别名 | |||
英文别名 | P505-15;PRT062607;PRT-062607;PRT 062607; | ||
SMILES | |||
化学名称 | |||
分子式 | C19H23N9O.HCl | 分子量 | 429.91 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | in vitro: P505-15 successfully inhibited SYK-mediated B-cell receptor signaling and decreased cell viability in NHL and CLL [1]. PRT318 and P505-15 effectively antagonize CLL cell survival after BCR triggering and in nurse-like cell-co-cultures. Moreover, they inhibit BCR-dependent secretion of the chemokines CCL3 and CCL4 by CLL cells, and leukemia cell migration toward the tissue homing chemokines CXCL12, CXCL13, and beneath stromal cells. in vivo: Oral dosing in mice prevented BCR-mediated splenomegaly and significantly inhibited NHL tumor growth in a xenograft model. In addition, combination treatment of primary CLL cells with P505-15 plus fludarabine produced synergistic enhancement of activity at nanomolar concentrations. |
相关产品推荐
查看更多 >Tags:PRT062607 HCl 供应商,PRT062607 HCl 购买,PRT062607 HCl 生产,PRT062607 HCl 批量,PRT062607 HCl 供应,PRT062607 HCl 订购,PRT062607 HCl 采购